Early occurrence and recurrence of hepatocellular carcinoma in hepatitis C virus-infected patients after sustained virological response
Authors:
Open Access
- 1 March 2018
- journal article
- editorial
- Published by Springer Nature in Hepatology International
- Vol. 12 (2) , 90-93
Abstract
No abstract availableFunding Information
- Japan Agency for Medical Research and Development (JP16jk0210014)
- JSPS KAKENHI (17K09404)
This publication has 28 references indexed in Scilit:
- Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapyJournal of Hepatology, 2016
- The tertiary prevention of hepatocellular carcinoma in chronic hepatitis C patientsJournal of Gastroenterology and Hepatology, 2015
- Restoration of HCV-specific CD8+ T cell function by interferon-free therapyJournal of Hepatology, 2014
- APASL consensus statements and management algorithms for hepatitis C virus infectionHepatology International, 2012
- Occurrence of Hepatocellular Carcinoma Was Not a Rare Event during and Immediately after Antiviral Treatment in Japanese HCV-Positive PatientsOncology, 2011
- New antiviral therapies for chronic hepatitis CHepatology International, 2010
- Meta‐analysis: interferon improves outcomes following ablation or resection of hepatocellular carcinomaAlimentary Pharmacology & Therapeutics, 2010
- Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose PeginterferonNew England Journal of Medicine, 2008
- Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C in JapanAnnals of Internal Medicine, 1999
- Randomised trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosisThe Lancet, 1995